A detailed history of Cresset Asset Management, LLC transactions in Grifols Sa stock. As of the latest transaction made, Cresset Asset Management, LLC holds 21,831 shares of GRFS stock, worth $206,739. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,831
Previous 14,887 46.64%
Holding current value
$206,739
Previous $93,000 107.53%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.28 - $9.38 $43,608 - $65,134
6,944 Added 46.64%
21,831 $193,000
Q2 2024

Aug 14, 2024

BUY
$6.27 - $7.7 $93,341 - $114,629
14,887 New
14,887 $93,000
Q2 2023

Aug 14, 2023

BUY
$7.14 - $9.29 $80,160 - $104,298
11,227 New
11,227 $102,000
Q2 2019

Aug 12, 2019

SELL
$17.59 - $21.1 $50,852 - $61,000
-2,891 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$18.01 - $20.11 $8,572 - $9,572
476 Added 19.71%
2,891 $58,000
Q4 2018

May 21, 2019

BUY
$17.44 - $21.53 $42,117 - $51,994
2,415 New
2,415 $44,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $6.43B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.